INVA RSI Chart
Last 7 days
1.6%
Last 30 days
-4.9%
Last 90 days
-7.0%
Trailing 12 Months
37.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 326.1M | 320.9M | 315.7M | 310.5M |
2022 | 376.7M | 361.6M | 346.5M | 331.3M |
2021 | 350.6M | 364.3M | 378.1M | 391.9M |
2020 | 284.5M | 299.4M | 322.3M | 336.8M |
2019 | 263.8M | 260.8M | 264.9M | 261.0M |
2018 | 229.1M | 237.6M | 250.7M | 261.0M |
2017 | 149.9M | 176.0M | 191.3M | 217.2M |
2016 | 71.2M | 93.0M | 112.8M | 133.6M |
2015 | 16.1M | 25.8M | 38.4M | 53.9M |
2014 | 5.5M | 6.5M | 7.5M | 8.4M |
2013 | 5.3M | 5.1M | 4.8M | 4.5M |
2012 | 145.3M | 140.3M | 135.3M | 5.6M |
2011 | 24.3M | 24.4M | 24.4M | 24.5M |
2010 | 0 | 0 | 0 | 24.2M |
2009 | 0 | 0 | 0 | 24.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 05, 2024 | ronsheim matthew | acquired | 189,988 | 14.88 | 12,768 | see remarks |
Mar 05, 2024 | zhen marianne | acquired | 159,990 | 14.88 | 10,752 | chief accounting officer |
Mar 05, 2024 | basso stephen | acquired | 179,988 | 14.88 | 12,096 | chief financial officer |
Feb 20, 2024 | ronsheim matthew | sold (taxes) | -12,750 | 15.8 | -807 | see remarks |
Feb 20, 2024 | zhen marianne | sold (taxes) | -45,219 | 15.8 | -2,862 | chief accounting officer |
Jan 18, 2024 | ronsheim matthew | sold (taxes) | -25,680 | 16.05 | -1,600 | see remarks |
Nov 20, 2023 | zhen marianne | sold (taxes) | -10,678 | 13.62 | -784 | chief accounting officer |
Nov 15, 2023 | zhen marianne | sold | -153,810 | 13.9903 | -10,994 | chief accounting officer |
Nov 15, 2023 | zhen marianne | acquired | - | - | 302 | chief accounting officer |
Aug 18, 2023 | zhen marianne | sold (taxes) | -10,707 | 13.64 | -785 | chief accounting officer |
Which funds bought or sold INVA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -2.32 | 123,485 | 722,442 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -0.07 | 20,408,100 | 107,668,000 | -% |
Mar 05, 2024 | GERBER, LLC | new | - | 550,172 | 550,172 | 0.50% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 102 | 19,872,900 | 33,094,700 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.94 | 94,515 | 518,028 | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 67,000 | 349,000 | -% |
Feb 20, 2024 | Pacific Center for Financial Services | unchanged | - | 610 | 3,208 | -% |
Feb 16, 2024 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | reduced | -93.26 | -1,785,830 | 162,004 | -% |
Feb 16, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 32.41 | 11,289 | 29,289 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 2.82 | 169,000 | 796,000 | -% |
Unveiling Innoviva Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Innoviva Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Innoviva Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 27.6% | 86.00 | 67.00 | 67.00 | 66.00 | 66.00 | 67.00 | 81.00 | 94.00 | 108 | 98.00 | 95.00 | 93.00 | 90.00 | 89.00 | 79.00 | 79.00 | 76.00 | 66.00 | 64.00 | 55.00 | 80.00 |
Costs and Expenses | 231.8% | 25.00 | -18.69 | 75.00 | 35.00 | 130 | -219 | 88.00 | 45.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | -219 | 26.00 | 12.00 | 77.00 | -25.31 | 4.00 | 6.00 | 6.00 | 4.00 | 3.00 | 3.00 | 2.00 | 5.00 | 4.00 | 3.00 | 3.00 |
S&GA Expenses | -8.1% | 26.00 | 29.00 | 24.00 | 20.00 | 17.00 | 28.00 | 12.00 | 6.00 | 3.00 | 3.00 | 4.00 | 6.00 | 5.00 | 3.00 | 3.00 | 3.00 | 2.00 | 5.00 | 4.00 | 3.00 | 3.00 |
R&D Expenses | -40.9% | 2.00 | 4.00 | 15.00 | 13.00 | 10.00 | 12.00 | 14.00 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | - | - | - | - | - | - |
EBITDA Margin | 129.8% | 0.74* | 0.32* | 0.94* | 0.97* | 0.96* | 1.27* | 0.76* | 1.04* | 1.22* | 1.35* | 1.21* | 1.20* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 35.4% | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 3.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Income Taxes | -108.8% | -0.34 | 4.00 | 5.00 | 6.00 | 4.00 | 57.00 | -0.90 | 7.00 | 11.00 | 21.00 | 25.00 | 20.00 | 16.00 | 9.00 | 20.00 | 16.00 | 12.00 | 11.00 | 10.00 | 9.00 | -196 |
Earnings Before Taxes | -28.8% | 61.00 | 86.00 | 6.00 | 41.00 | -64.69 | 286 | 20.00 | 45.00 | 56.00 | 123 | 136 | 129 | 91.00 | 50.00 | 118 | 95.00 | 70.00 | 58.00 | 56.00 | 49.00 | 73.00 |
EBT Margin | 189.3% | 0.63* | 0.22* | 0.84* | 0.87* | 0.87* | 1.18* | 0.68* | 0.96* | 1.14* | 1.27* | 1.12* | 1.11* | - | - | - | - | - | - | - | - | - |
Net Income | -25.0% | 62.00 | 82.00 | 1.00 | 35.00 | -10.31 | 229 | 21.00 | 38.00 | -6.05 | 103 | 111 | 110 | -6.62 | 42.00 | 98.00 | 79.00 | 58.00 | 47.00 | 46.00 | 40.00 | 269 |
Net Income Margin | 69.4% | 0.58* | 0.34* | 0.80* | 0.84* | 0.84* | -0.09* | 0.88* | 0.84* | 0.81* | 0.84* | 0.70* | 0.69* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -24.3% | 33.00 | 44.00 | 38.00 | 26.00 | 9.00 | 16.00 | 79.00 | 98.00 | 98.00 | 97.00 | 85.00 | 84.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 4.7% | 1,244 | 1,188 | 1,118 | 1,130 | 1,231 | 1,328 | 1,138 | 1,107 | 926 | 887 | 789 | 1,088 | 1,000 | 922 | 880 | 788 | 725 | 676 | 642 | 590 | 548 |
Current Assets | 12.9% | 344 | 305 | 324 | 296 | 444 | 33.00 | 400 | 318 | 314 | 14.00 | 148 | 373 | 342 | 17.00 | 500 | 467 | 431 | 367 | 318 | 252 | 199 |
Cash Equivalents | 7.5% | 194 | 180 | 173 | 144 | 291 | 301 | 284 | 217 | 202 | 135 | 43.00 | 283 | 246 | 479 | 413 | 352 | 278 | 173 | 142 | 65.00 | 62.00 |
Inventory | 0.5% | 41.00 | 41.00 | 47.00 | 50.00 | 56.00 | 71.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | 33.8% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0% | 18.00 | 18.00 | 15.00 | 28.00 | 27.00 | 16.00 | 6.00 | 6.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Liabilities | 5.4% | 38.00 | 36.00 | 39.00 | 38.00 | 135 | 7.00 | 126 | 109 | 6.00 | 9.00 | 5.00 | 4.00 | 6.00 | 7.00 | 5.00 | 3.00 | 5.00 | 3.00 | 7.00 | 4.00 | 6.00 |
Long Term Debt | 0.1% | 446 | 446 | 445 | 445 | 444 | 444 | 443 | 443 | 395 | 392 | 390 | 388 | 386 | 383 | 381 | 379 | 377 | 389 | 387 | 385 | 383 |
LT Debt, Current | - | - | - | - | - | 96.00 | 96.00 | 96.00 | 96.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.1% | 446 | 446 | 445 | 445 | 444 | 444 | 443 | 443 | 395 | 392 | 390 | 388 | 386 | 383 | 381 | 379 | 377 | 389 | 387 | 385 | 383 |
Shareholder's Equity | 7.6% | 675 | 627 | 555 | 561 | 566 | 641 | 565 | 552 | 526 | 492 | 394 | 697 | 608 | 535 | 493 | 406 | 342 | 284 | 247 | 200 | 159 |
Retained Earnings | 71.0% | -25.19 | -86.72 | -168 | -170 | -204 | -136 | -402 | -403 | -456 | -466 | -538 | -627 | -722 | -775 | -804 | -880 | -946 | -992 | -1,032 | -1,069 | -1,103 |
Additional Paid-In Capital | -1.3% | 1,093 | 1,107 | 1,117 | 1,125 | 1,164 | 1,171 | 1,184 | 1,183 | 1,264 | 1,262 | 1,262 | 1,261 | 1,261 | 1,260 | 1,260 | 1,259 | 1,259 | 1,258 | 1,258 | 1,257 | 1,256 |
Shares Outstanding | -1.7% | 63.00 | 64.00 | 65.00 | 66.00 | 69.00 | 70.00 | 70.00 | 70.00 | 82.00 | 69.00 | 95.00 | 101 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | 177 | 166 | 111 | 89.00 | 64.00 | 62.00 | 68.00 | 49.00 | 36.00 | 26.00 | 29.00 | 17.00 | 20.00 | 12.00 | 5.00 |
Float | - | - | - | 731,927 | - | - | - | 924 | - | - | - | 840,847 | - | - | - | 877 | - | - | - | 1,006 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -24.3% | 33,256 | 43,942 | 38,182 | 25,684 | 8,899 | 15,690 | 79,035 | 98,102 | 98,381 | 96,711 | 84,614 | 84,107 | 85,280 | 74,558 | 79,794 | 73,481 | 66,905 | 57,402 | 56,496 | 76,655 | 61,777 |
Share Based Compensation | -11.4% | 1,277 | 1,442 | 1,520 | 1,598 | 1,326 | 3,717 | 1,350 | 954 | 554 | 542 | 470 | 451 | 447 | 441 | 375 | 435 | 488 | 489 | 474 | 605 | 486 |
Cashflow From Investing | 80.1% | -5,151 | -25,888 | - | -35,722 | -8,678 | 97,722 | -2,522 | -143,156 | -19,905 | - | 90,021 | -26,394 | -315,481 | -8,500 | -7,000 | 16,044 | 51,994 | -15,937 | 20,107 | -74,167 | -45,594 |
Cashflow From Financing | -31.6% | -14,589 | -11,082 | -9,206 | -136,962 | -10,001 | -96,163 | -9,735 | 60,331 | -12,066 | -4,861 | -414,260 | -21,310 | -2,505 | -12.00 | -11,628 | -15,640 | -13,749 | -10,471 | 198 | 246 | -2,381 |
Dividend Payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.00 | 8.00 | 8.00 |
Buy Backs | 32.2% | 14,636 | 11,071 | 9,286 | 40,735 | 8,503 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue: | |||
Total revenue | $ 310,463 | $ 331,339 | $ 391,866 |
Expenses: | |||
Selling, general and administrative | 98,232 | 63,538 | 16,187 |
Research and development | 33,922 | 41,432 | 576 |
Amortization of acquired intangible assets | 21,784 | 5,581 | 0 |
Gain on sale of Theravance Respiratory Company, LLC ("TRC") | 0 | (266,696) | 0 |
Loss on extinguishment of debt | 0 | 20,662 | 0 |
Changes in fair values of equity method investments, net | (77,392) | 161,749 | (84,392) |
Changes in fair value of equity and long-term investments, net | (11,129) | (8,462) | (6,638) |
Interest and dividend income | (15,818) | (6,369) | (1,839) |
Interest expense | 19,157 | 15,789 | 19,070 |
Other expense, net | 4,969 | 3,373 | 3,626 |
Total expenses, net | 116,365 | 44,390 | (53,410) |
Income before income taxes | 194,098 | 286,949 | 445,276 |
Income tax expense, net | 14,376 | 66,687 | 76,439 |
Net income | 179,722 | 220,262 | 368,837 |
Net loss attributable to noncontrolling interests | 0 | 6,341 | 102,983 |
Net income attributable to Innoviva stockholders | $ 179,722 | $ 213,921 | $ 265,854 |
Basic net income per share attributable to Innoviva stockholders | $ 2.75 | $ 3.07 | $ 3.24 |
Diluted net income per share attributable to Innoviva stockholders | $ 2.2 | $ 2.37 | $ 2.87 |
Shares used to compute Innoviva basic and diluted net income per share: | |||
Shares used to compute basic net income per share | 65,435 | 69,644 | 82,062 |
Shares used to compute diluted net income per share | 86,876 | 95,248 | 94,310 |
Royalty revenue | |||
Revenue: | |||
Total revenue | $ 238,846 | $ 311,645 | $ 391,866 |
Net product sales | |||
Revenue: | |||
Total revenue | 60,617 | 19,694 | 0 |
Expenses: | |||
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets) | 41,040 | 13,793 | 0 |
License revenue | |||
Revenue: | |||
Total revenue | 11,000 | 0 | 0 |
License | |||
Expenses: | |||
Cost of license revenue | $ 1,600 | $ 0 | $ 0 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 193,513 | $ 291,049 |
Accounts receivable | 14,454 | 9,401 |
Receivables from collaboration arrangements | 69,621 | 54,672 |
Inventory | 40,737 | 55,897 |
Prepaid expenses | 21,630 | 29,559 |
Other current assets | 4,264 | 2,933 |
Total current assets | 344,219 | 443,511 |
Property and equipment, net | 483 | 170 |
Equity method investments | 116,546 | 39,154 |
Equity and long-term investments | 444,432 | 363,859 |
Capitalized fees paid, net | 83,784 | 97,607 |
Right-of-use assets | 2,536 | 3,265 |
Goodwill | 17,905 | 26,713 |
Intangible assets | 230,335 | 252,919 |
Other assets | 3,267 | 4,299 |
Total assets | 1,243,507 | 1,231,497 |
Current liabilities: | ||
Accounts payable | 6,717 | 2,939 |
Accrued personnel-related expenses | 7,020 | 8,022 |
Accrued interest payable | 3,422 | 4,359 |
Deferred revenue | 1,277 | 2,094 |
Convertible subordinated notes due 2023, net of issuance costs | 0 | 96,193 |
Income tax payable | 0 | 154 |
Other accrued liabilities | 19,698 | 21,207 |
Total current liabilities | 38,134 | 134,968 |
Long-term debt, net of discount and issuance costs | 446,234 | 444,180 |
Other long-term liabilities | 71,870 | 70,918 |
Deferred tax liabilities, net | 563 | 5,771 |
Income tax payable, long-term | 11,751 | 9,872 |
Commitments and contingencies (Note 13) | ||
Stockholders' equity: | ||
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding | 0 | 0 |
Common stock: $0.01 par value, 200,000 shares authorized, 69,307 and 69,188 issued and outstanding as of December 31, 2023 and December 31, 2022 respectively | 633 | 692 |
Treasury stock: at cost, 32,005 shares as of December 31, 2023 and 2022 | (393,829) | (393,829) |
Additional paid-in capital | 1,093,340 | 1,163,836 |
Accumulated deficit | (25,189) | (204,911) |
Total stockholders' equity | 674,955 | 565,788 |
Total liabilities and stockholders' equity | $ 1,243,507 | $ 1,231,497 |
 | www.inva.com |
---|---|
 | 101 |